Altre lingue Cognetivity Neurosciences Ltd.

Azioni

CGN

CA19243C1005

Tempo differito Canadian Securities Exchange Altri mercati azionari 21:16:21 18/04/2024			Variaz. 5gg	Var. 1 gen.
0,02 ^CAD	+33,33%		-20,00%	+33,33%

2023	Cognetivity Neurosciences Ltd. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 ottobre 2023	CI
2023	Cognetivity Neurosciences Ltd. e Uc Health collaborano per migliorare il rilevamento precoce del deterioramento cognitivo negli Usa	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	29/12
CognICA(TM) Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service	24/10/23
Cognetivity Neurosciences Ltd. announced that it has received CAD 0.01 million in funding	17/10/23
Cognetivity Neurosciences Ltd. and Uc Health Partner to Improve Early Detection of Cognitive Impairment in Usa	11/10/23
Cognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA	11/10/23
Cognetivity Neurosciences Ltd. Announces Collaboration with the Mediclinic Group	03/10/23
Cognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s	03/10/23
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	29/09/23
Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology	21/09/23
Cognetivity Neurosciences Ltd. announced that it expects to receive CAD 0.01 million in funding	15/09/23
Cognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award	13/09/23
Cognetivity Neurosciences Ltd. Announces Eisai's Leqembi Approval for the Treatment of Alzheimer's Disease	07/07/23
Cognetivity Neurosciences Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2023	30/06/23
Clairvo Technologies, Inc. Announces Strategic Partnership with Cognetivity Neurosciences, Inc	13/06/23
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023	09/06/23
Cognetivity Neurosciences Ltd. Auditor Raises 'Going Concern' Doubt	09/06/23
Cognetivity Neurosciences Ltd. Announces Collaboration with the Alzheimer's Society to Further Expand Its AI Algorithms	31/05/23
Cognetivity Neurosciences Ltd. Announces Agreement with Mitsui Sumitomo Aioi Life Insurance of Japan to Provide CognICA Technology to Customers	25/04/23
Cognetivity Neurosciences : Announces Agreement With Japanese Life Insurance Company	25/04/23
Cognetivity Neurosciences Ltd. Appoints Karimah Es Sabar to Its Board Director	20/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Cognetivity Neurosciences Ltd.

Azioni

CGN

CA19243C1005

Altre lingue

Filtri